What is the appropriate cephalexin (Keflex) dose for a 12‑year‑old child weighing approximately 40‑50 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin (Keflex) Dosing for a 12-Year-Old

For a 12-year-old child weighing 40–50 kg, the standard cephalexin dose is 25–50 mg/kg/day divided into 3–4 doses (every 6–8 hours), which translates to approximately 1,000–2,500 mg total daily dose, typically given as 250–500 mg every 6 hours or 500–750 mg every 8–12 hours depending on infection severity. 1

Weight-Based Dosing Algorithm

Standard Dosing for Most Infections

  • The FDA-approved pediatric dosing is 25–50 mg/kg/day divided into doses every 6–8 hours. 1
  • For a 40 kg child: this equals 1,000–2,000 mg/day (250–500 mg every 6 hours, or 333–667 mg every 8 hours). 1
  • For a 50 kg child: this equals 1,250–2,500 mg/day (312–625 mg every 6 hours, or 417–833 mg every 8 hours). 1

Practical Dosing Regimens

For mild-to-moderate infections (skin/soft tissue, uncomplicated UTI, pharyngitis):

  • 250–500 mg every 6 hours (four times daily), or
  • 500 mg every 12 hours (twice daily) for streptococcal pharyngitis and uncomplicated skin infections. 1

For more severe infections or less susceptible organisms:

  • 500 mg every 6 hours (2,000 mg/day total). 1
  • The FDA label states that "for more severe infections or those caused by less susceptible organisms, larger doses may be needed." 1

Otitis Media (Specific Indication)

  • Clinical studies demonstrate that 75–100 mg/kg/day in 4 divided doses is required for otitis media. 1
  • For a 40–50 kg child, this translates to 750–1,250 mg every 6 hours (3,000–5,000 mg/day total). 1

Infection-Specific Considerations

Streptococcal Pharyngitis

  • Minimum 10-day course is mandatory to prevent rheumatic fever complications. 1
  • Either 250–500 mg every 6 hours or 500 mg every 12 hours is acceptable. 1

Skin and Soft Tissue Infections (Staphylococcus aureus)

  • For methicillin-susceptible S. aureus (MSSA), cephalexin is first-line therapy. 2, 3
  • The IDSA/PIDS guidelines recommend 75–100 mg/kg/day in 3–4 divided doses for oral step-down therapy. 2
  • Recent pharmacokinetic studies support less frequent dosing: 22–45 mg/kg/dose three times daily achieves adequate drug levels for MSSA with MIC ≤2 mg/L. 3, 4

Urinary Tract Infections

  • Cephalexin achieves urinary concentrations of 500–1,000 mcg/mL following 250–500 mg oral doses, far exceeding MICs for common uropathogens. 5, 6
  • Therapy should continue for 7–14 days for cystitis. 1

Alternative Dosing Frequencies to Improve Adherence

Three-Times-Daily Dosing

  • Recent evidence supports 45 mg/kg/dose (maximum 1.5 g) three times daily for bone/joint infections, with 99% cure rates and good tolerability. 4
  • For a 40–50 kg child: 1,500 mg three times daily (at the maximum cap). 4
  • This regimen reduces pill burden compared to four-times-daily dosing while maintaining efficacy. 3, 4

Twice-Daily Dosing

  • Pharmacokinetic modeling suggests 22–45 mg/kg/dose twice daily achieves targets for MSSA with MIC ≤2 mg/L. 3
  • For streptococcal pharyngitis and uncomplicated skin infections, 500 mg every 12 hours is FDA-approved for patients >15 years. 1
  • A 12-year-old at 40–50 kg approaches adult weight thresholds and may use 500–750 mg twice daily for appropriate indications. 1

Maximum Dose Limitations

  • Daily doses >4 g require consideration of parenteral cephalosporins rather than escalating oral cephalexin further. 1
  • For severe infections requiring aggressive dosing, ceftriaxone 50–100 mg/kg/day IV (maximum 2–4 g/day) is preferred over high-dose oral cephalexin. 2, 7

Common Pitfalls and Caveats

Do Not Underdose Serious Infections

  • The lower end of the dosing range (25 mg/kg/day) is insufficient for bone/joint infections, severe skin infections, or otitis media—always use 75–100 mg/kg/day for these indications. 1, 4

Cephalexin Has Limited Spectrum

  • Cephalexin is inactive against Borrelia burgdorferi (Lyme disease), atypical respiratory pathogens (Mycoplasma, Chlamydia), and many gram-negative organisms beyond E. coli and Proteus. 2, 8
  • For community-acquired pneumonia, amoxicillin 90 mg/kg/day or ceftriaxone is preferred over cephalexin because cephalexin has poor activity against Streptococcus pneumoniae and Haemophilus influenzae. 2, 9

Refrigeration and Stability

  • Oral suspension must be refrigerated and discarded after 14 days. 1

Renal Dosing Adjustment

  • Patients with creatinine clearance <30 mL/min require dose reduction proportional to renal function. 5

Clinical Monitoring

  • Clinical improvement should occur within 48–72 hours; lack of response warrants reassessment for resistant organisms, abscess formation, or alternative diagnoses. 9
  • For streptococcal infections, complete the full 10-day course even if symptoms resolve earlier. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Research

Cephalexin in the therapy of infections of the urinary tract.

Postgraduate medical journal, 1983

Guideline

Pediatric Dosing of Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pediatric Cefuroxime Axetil Dosing and Clinical Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.